News

Patient Care Pioneer Award

Published on: 04/03/2025

Patient Care Pioneer Award

Our Patient Care Pioneer Award provides funding for healthcare professionals to undertake innovative, patient-centred projects that will improve treatment, care, and quality of life for leukaemia patients.

Funding news

Leukaemia UK is delighted to announce that we will once again be offering PCPA funding in 2025.

The Patient Care Pioneer Award is intended to provide funding specifically for patient-focussed applied research. The funding is offered for innovative patient-centred projects that seek to explore new practical approaches to improve treatment, care, and quality of life for leukaemia patients. The expectation is that the research will be of short duration to provide rapid proof of principle/evidence to address an unmet patient need, or to develop a proposed practice-changing improvement for the benefit of patient treatment and care, or to generate robust preliminary data for a subsequent funding application.

The proposed research must have direct relevance to leukaemia and/or related diseases. The remit of the funding is intentionally broad and can address any aspect of leukaemia patient care, quality of life or treatment, including post-treatment. Successfully funded projects should demonstrate the opportunity or potential to make a real difference to leukaemia patients and their families.

Please note:

  • The funding is not intended to fund gaps in NHS services. However, the award can be used to highlight a need or improvement that could subsequently be used to campaign for change to NHS practice.
  • The funding is also not intended to be used as an educational grant for the award holder. However, the award can be used to fund specific training that is necessary to enable the award holder to undertake the proposed project successfully, including training that may be part of the award holder’s education programme (e.g., a master’s qualification).

We would particularly welcome applications that seek to address an unmet need or develop a practice-changing improvement for patients in communities that are poorly-served or underrepresented in research.

The remit of this funding call covers unmet need across all leukaemia patients, but proposals may be focussed on particular patient groupings – this entirely optional.

Applicants may wish to refer to published James Lind Alliance Priory Setting Partnerships (PSPs) on: children’s cancer (2022), teenage and young adult cancer (2018) and living with and beyond cancer (2018) if relevant. Please note that the leukaemia representation across these three PSPs is likely highest in the children’s cancer PSP. However, applications to the Leukaemia UK Patient Care Pioneer Award focussed on childhood leukaemia will not be viewed preferentially over applications focussed on adults, elderly or teenagers / young adults. Applications are not required to reference or address the published PSP priority topics, or be driven by their rank ordering.

Who can apply?

Applications are invited from UK-based healthcare professionals, particularly nurses and other allied healthcare professionals, at any stage of their career working within the haematology and associated communities.

Grants are for up to £50,000 to span a 6-18 month period.

Nurse looking at clipboard with a face mask and gloves on

Application process

Applications for the 2025 awards will open on 10 February 2025, with a submission deadline of midday on Friday 02 May 2025. All applicants will be informed of the outcome of their application by 31 July 2025.

Applications must be submitted via the Leukaemia UK Funding Management System. In order to submit an application, applicants are required to register for an account in the Leukaemia UK Funding Management System, as are the applicant’s Head of Department (or equivalent), Institutional Finance Approver and any Co-applicants, all of whom are also required to approve the application prior to the submission deadline.

We therefore suggest that applicants begin their applications as soon as possible, to avoid any delays with the submission process. Applications can be saved in the system and updated at any time prior to the submission deadline. A detailed user guide for the Leukaemia UK FMS and a sample PCPA application form are available.

Please also read our full Patient Care Pioneer Award guidance and Terms and Conditions before starting your application.

We funded one PCPA in 2024.

Previous Outcomes

Year No. of awards % of applications funded
2024 1 33%

Questions?

If you have any questions or queries regarding Leukaemia UK’s Patient Care Pioneer Award, please email our Research Manager, Dr Tom Simpson.

NEWS​

Related News

HLTH Brought the Energy to Amsterdam. Now It’s Vegas’ Turn.

26 Jun 2025
Next up: HLTH USA, October 19–22 in Las Vegas.

From Abandonment to Belonging: Hands 4Life’s Vision for Generational Healing

26 Jun 2025
Hands 4Life is a nonprofit organization addressing the global aging crisis by empowering communities in economically developing nations—beginning with...

Strengthening Elderly Care Innovation Across Europe: ECHAlliance at the NOTRE Project Meeting in Lille

26 Jun 2025
ECHAlliance participated in the latest partner meeting of the NOTRE Project, hosted in Lille, France by our Hauts-de-France ecosystem led by Eurasanté...

Africa Health Business Co-founder Dr Amit Thakker Honoured with Top Civilian Award

26 Jun 2025
Dr. Amit N. Thakker, Co-founder of our partner Africa Health Business, receives one of the highest civilian awards from the President of Kenya.

Highlights from the Global Health Connector Partners Programme at HLTH Europe 2025

25 Jun 2025
Our Global Health Connector Partners Programme returned to HLTH Europe this June with an energising series of sessions, conversations and connections ...

That’s a Wrap from HIMSS Europe 2025!

24 Jun 2025
From Paris with purpose: Gnomon Informatics SA returned to HIMSS Europe for a third year of bold ideas, smart tech, and stronger-than-ever momentum in...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *